Common acne medication offers new treatment for multiple sclerosis

Study results offer safe and affordable treatment option.

A Canadian clinical trial led by researchers at the University of Calgary's Hotchkiss Brain Institute (HBI), at the Cumming School of Medicine (CSM), shows that minocycline, a common acne medication, can slow the progress of relapsing-remitting multiple sclerosis (MS) in people who have recently experienced their first symptoms.

In addition to being an unexpected discovery - an acne drug benefitting a neurological disorder - the discovery is significant as it offers a safe and affordable treatment option for those with early onset…

Favicon of www.medicalnewstoday.com da : www.medicalnewstoday.com

Prosegui la lettura...

Sclerosi Multipla News

Potrebbe interessarti anche

Argomenti correlati

Pubblicità

Pubblicità